Merck is preferred over Moderna due to its involvement in the cancer vaccine research, offering a less volatile entry point.
Source Post
URGENTE EN CNBC: LLAMAN A COMPRAR CALLS DE MICRON ANTES DE SU REPORTE + MICROSOFT Y CRM !!
Sep 26, 2026
The creator discusses upcoming earnings reports, highlighting Micron's upcoming report as a significant event. They mention a technical analysis prediction for Micron from CNBC's Fast Money program, suggesting a potential move to $95. Additionally, the creator notes that Fast Money also recommended buying Salesforce (CRM).
Linked Mentions
Tickers discussed in this post
The creator mentions taking a trade on Meta Platforms (Mera) this week, which was also published on Patreon.
Tim Seer is calling to buy Microsoft (MSFT), noting that the stock is consolidating.
CNBC's Fast Money program recommended buying Salesforce (CRM), stating it's time to buy.
Linked Signals
Tracked calls opened from this post
buy opened Sep 26, 2026
+0.00%